Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 498

1.

The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.

Passarelli MK, Pirkl A, Moellers R, Grinfeld D, Kollmer F, Havelund R, Newman CF, Marshall PS, Arlinghaus H, Alexander MR, West A, Horning S, Niehuis E, Makarov A, Dollery CT, Gilmore IS.

Nat Methods. 2017 Dec;14(12):1175-1183. doi: 10.1038/nmeth.4504. Epub 2017 Nov 13.

PMID:
29131162
2.

Intracellular Drug Uptake-A Comparison of Single Cell Measurements Using ToF-SIMS Imaging and Quantification from Cell Populations with LC/MS/MS.

Newman CF, Havelund R, Passarelli MK, Marshall PS, Francis I, West A, Alexander MR, Gilmore IS, Dollery CT.

Anal Chem. 2017 Nov 21;89(22):11944-11953. doi: 10.1021/acs.analchem.7b01436. Epub 2017 Nov 8.

PMID:
29039651
3.

High-resolution sub-cellular imaging by correlative NanoSIMS and electron microscopy of amiodarone internalisation by lung macrophages as evidence for drug-induced phospholipidosis.

Jiang H, Passarelli MK, Munro PM, Kilburn MR, West A, Dollery CT, Gilmore IS, Rakowska PD.

Chem Commun (Camb). 2017 Jan 26;53(9):1506-1509. doi: 10.1039/c6cc08549k.

PMID:
28085162
4.

Semiempirical Rules To Determine Drug Sensitivity and Ionization Efficiency in Secondary Ion Mass Spectrometry Using a Model Tissue Sample.

Vorng JL, Kotowska AM, Passarelli MK, West A, Marshall PS, Havelund R, Seah MP, Dollery CT, Rakowska PD, Gilmore IS.

Anal Chem. 2016 Nov 15;88(22):11028-11036. Epub 2016 Oct 26.

PMID:
27726375
5.

Single-Cell Analysis: Visualizing Pharmaceutical and Metabolite Uptake in Cells with Label-Free 3D Mass Spectrometry Imaging.

Passarelli MK, Newman CF, Marshall PS, West A, Gilmore IS, Bunch J, Alexander MR, Dollery CT.

Anal Chem. 2015 Jul 7;87(13):6696-702. doi: 10.1021/acs.analchem.5b00842. Epub 2015 Jun 23.

PMID:
26023862
6.

The Concise Guide to PHARMACOLOGY 2013/14: overview.

Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, McGrath JC, Catterall WA, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators, Abul-Hasn N, Anderson CM, Anderson CM, Araiksinen MS, Arita M, Arthofer E, Barker EL, Barratt C, Barnes NM, Bathgate R, Beart PM, Belelli D, Bennett AJ, Birdsall NJ, Boison D, Bonner TI, Brailsford L, Bröer S, Brown P, Calo G, Carter WG, Catterall WA, Chan SL, Chao MV, Chiang N, Christopoulos A, Chun JJ, Cidlowski J, Clapham DE, Cockcroft S, Connor MA, Cox HM, Cuthbert A, Dautzenberg FM, Davenport AP, Dawson PA, Dent G, Dijksterhuis JP, Dollery CT, Dolphin AC, Donowitz M, Dubocovich ML, Eiden L, Eidne K, Evans BA, Fabbro D, Fahlke C, Farndale R, Fitzgerald GA, Fong TM, Fowler CJ, Fry JR, Funk CD, Futerman AH, Ganapathy V, Gaisnier B, Gershengorn MA, Goldin A, Goldman ID, Gundlach AL, Hagenbuch B, Hales TG, Hammond JR, Hamon M, Hancox JC, Hauger RL, Hay DL, Hobbs AJ, Hollenberg MD, Holliday ND, Hoyer D, Hynes NA, Inui KI, Ishii S, Jacobson KA, Jarvis GE, Jarvis MF, Jensen R, Jones CE, Jones RL, Kaibuchi K, Kanai Y, Kennedy C, Kerr ID, Khan AA, Klienz MJ, Kukkonen JP, Lapoint JY, Leurs R, Lingueglia E, Lippiat J, Lolait SJ, Lummis SC, Lynch JW, MacEwan D, Maguire JJ, Marshall IL, May JM, McArdle CA, McGrath JC, Michel MC, Millar NS, Miller LJ, Mitolo V, Monk PN, Moore PK, Moorhouse AJ, Mouillac B, Murphy PM, Neubig RR, Neumaier J, Niesler B, Obaidat A, Offermanns S, Ohlstein E, Panaro MA, Parsons S, Pwrtwee RG, Petersen J, Pin JP, Poyner DR, Prigent S, Prossnitz ER, Pyne NJ, Pyne S, Quigley JG, Ramachandran R, Richelson EL, Roberts RE, Roskoski R, Ross RA, Roth M, Rudnick G, Ryan RM, Said SI, Schild L, Sanger GJ, Scholich K, Schousboe A, Schulte G, Schulz S, Serhan CN, Sexton PM, Sibley DR, Siegel JM, Singh G, Sitsapesan R, Smart TG, Smith DM, Soga T, Stahl A, Stewart G, Stoddart LA, Summers RJ, Thorens B, Thwaites DT, Toll L, Traynor JR, Usdin TB, Vandenberg RJ, Villalon C, Vore M, Waldman SA, Ward DT, Willars GB, Wonnacott SJ, Wright E, Ye RD, Yonezawa A, Zimmermann M.

Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.

7.

Lost in Translation (LiT): IUPHAR Review 6.

Dollery CT.

Br J Pharmacol. 2014 May;171(9):2269-90. doi: 10.1111/bph.12580. Review.

8.

Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women.

Caltabiano S, Dollery CT, Hossain M, Kurtinecz MT, Desjardins JP, Favus MJ, Kumar R, Fitzpatrick LA.

Bone. 2013 Sep;56(1):154-62. doi: 10.1016/j.bone.2013.05.021. Epub 2013 Jun 10.

PMID:
23756230
9.

Intracellular drug concentrations.

Dollery CT.

Clin Pharmacol Ther. 2013 Mar;93(3):263-6. doi: 10.1038/clpt.2012.240. Epub 2012 Dec 11. Review.

PMID:
23361104
10.

Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.

Spraggs CF, Parham LR, Hunt CM, Dollery CT.

Clin Pharmacol Ther. 2012 Apr;91(4):647-52. doi: 10.1038/clpt.2011.277. Epub 2012 Feb 22.

PMID:
22357454
11.

The challenge of complexity.

Dollery CT.

Clin Pharmacol Ther. 2010 Jul;88(1):13-5. doi: 10.1038/clpt.2009.267. No abstract available.

PMID:
20562888
12.

IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels.

Harmar AJ, Hills RA, Rosser EM, Jones M, Buneman OP, Dunbar DR, Greenhill SD, Hale VA, Sharman JL, Bonner TI, Catterall WA, Davenport AP, Delagrange P, Dollery CT, Foord SM, Gutman GA, Laudet V, Neubig RR, Ohlstein EH, Olsen RW, Peters J, Pin JP, Ruffolo RR, Searls DB, Wright MW, Spedding M.

Nucleic Acids Res. 2009 Jan;37(Database issue):D680-5. doi: 10.1093/nar/gkn728. Epub 2008 Oct 23.

13.

Clinical pharmacology in the molecular era.

Dollery CT.

Clin Pharmacol Ther. 2008 Feb;83(2):220-5. doi: 10.1038/sj.clpt.6100457.

PMID:
18202688
14.

The scientific contribution of clinical pharmacology.

Dollery CT.

Eur J Clin Pharmacol. 2008 Feb;64(2):99-106. doi: 10.1007/s00228-007-0420-3. Epub 2008 Jan 3. No abstract available.

PMID:
18172626
15.

Beyond genomics.

Dollery CT.

Clin Pharmacol Ther. 2007 Oct;82(4):366-70. Review.

PMID:
17851575
16.

Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators.

Gasowski J, Staessen JA, Celis H, Fagard RH, Thijs L, Birkenhäger WH, Bulpitt CJ, Fletcher AE, Arabidze GG, de Leeuw P, Dollery CT, Duggan J, Kawecka-Jaszcz K, Leonetti G, Nachev C, Safar M, Rodico JL, Rosenfeld J, Seux ML, Tuomilehto J, Webster J, Yodfat Y.

J Hum Hypertens. 1999 Feb;13(2):135-45.

PMID:
10100063
17.

Drug discovery and development in the molecular era.

Dollery CT.

Br J Clin Pharmacol. 1999 Jan;47(1):5-6. No abstract available.

18.

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A.

Lancet. 1997 Sep 13;350(9080):757-64.

PMID:
9297994
19.

Urinary leukotriene E4 levels in patients with atopic dermatitis.

Sansom JE, Taylor GW, Dollery CT, Archer CB.

Br J Dermatol. 1997 May;136(5):790-1.

PMID:
9205521
20.

Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertension Care Computing Project.

Palmer AJ, Fletcher AE, Bulpitt CJ, Beevers DG, Coles EC, Ledingham JG, Petrie JC, Webster J, Dollery CT.

J Hypertens. 1995 Sep;13(9):957-64.

PMID:
8586830
21.

An academy of medicine: a future for British postgraduate medicine?

Dollery CT.

Br J Hosp Med. 1995 Jul 12-Aug 15;54(2-3):64-7. No abstract available.

PMID:
7551491
22.

Frontiers in the development of new medicines in relation to clinical pharmacology.

Dollery CT.

Pharmacol Toxicol. 1995 May;76(5):334-8. Review. No abstract available.

PMID:
7567785
23.

Antihypertensive therapy in elderly patients with isolated systolic hypertension: third progress report of the Syst-Eur trial.

Thijs L, Amery A, Antikainen R, Bert P, Birkenhäger W, Bulpitt CJ, Dollery CT, Fletcher AE, Forette F, Hakamäki T, et al.

Clin Exp Hypertens. 1993 Nov;15(6):953-66.

PMID:
8268900
24.

Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma.

Clesham CJ, Kennedy A, Lavender JP, Dollery CT, Wilkins MR.

J Hum Hypertens. 1993 Aug;7(4):353-6.

PMID:
8410925
25.

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.

O'Shaughnessy KM, Taylor IK, O'Connor B, O'Connell F, Thomson H, Dollery CT.

Am Rev Respir Dis. 1993 Jun;147(6 Pt 1):1431-5.

PMID:
8389105
26.

Cancer mortality and atenolol treatment.

Fletcher AE, Beevers DG, Bulpitt CJ, Coles EC, Dollery CT, Ledingham JG, Palmer AJ, Petrie JC, Webster J.

BMJ. 1993 Mar 6;306(6878):622-3. No abstract available.

27.

An infected prosthetic hip. Is there a role for prophylactic antibiotics?

Mason JC, Dollery CT, So A, Cohen J, Bloom SR, Bulpitt C, Russell-Jones R, Oakley CM.

BMJ. 1992 Aug 1;305(6848):300-2. No abstract available.

28.
29.

Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans.

Taylor IK, Ward PS, Taylor GW, Dollery CT, Fuller RW.

J Appl Physiol (1985). 1991 Oct;71(4):1396-402.

PMID:
1661723
30.

Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization.

Amery A, Birkenhäger W, Bulpitt CJ, Clément D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forette F, Leonetti G, et al.

Aging (Milano). 1991 Sep;3(3):287-302.

PMID:
1764497
31.

Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1.

Ward PS, Fuller RW, Ritter JM, Cashman SJ, Rees AJ, Dollery CT.

Br J Pharmacol. 1991 Jul;103(3):1663-8.

32.

Assessment of MK-467, a peripheral alpha 2-adrenergic receptor antagonist, with intravenous clonidine.

Warren JB, Dollery CT, Sciberras D, Goldberg MR.

Clin Pharmacol Ther. 1991 Jul;50(1):71-7.

PMID:
1677320
33.
34.

Clinical pharmacology of calcium antagonists.

Dollery CT.

Am J Hypertens. 1991 Feb;4(2 Pt 2):88S-95S. Review.

PMID:
2021457
35.

Thromboxane A2 biosynthesis in acute asthma and after antigen challenge.

Taylor IK, Ward PS, O'Shaughnessy KM, Dollery CT, Black P, Barrow SE, Taylor GW, Fuller RW.

Am Rev Respir Dis. 1991 Jan;143(1):119-25.

PMID:
1986668
36.

The effects of two centrally-acting anti-hypertensive drugs on the quality of life.

Fletcher AE, Beevers DG, Dollery CT, Wilkinson R, Bulpitt CJ.

Eur J Clin Pharmacol. 1991;41(5):397-400.

PMID:
1684749
37.

Oral pharmacokinetics of fluazifop-butyl in human volunteers.

Woollen BH, Hart TB, Batten PL, Laird WJ, Davies DS, Dollery CT.

Hum Exp Toxicol. 1991 Jan;10(1):39-43.

PMID:
1673623
38.

Gastrinoma syndrome in multiple endocrine neoplasia.

Wynick D, Dollery CT, Bloom SR, Polak JM, Lynn JA.

BMJ. 1990 Sep 8;301(6750):489-90. No abstract available.

39.

Increased production of cysteinyl leukotrienes in hepatorenal syndrome.

Moore KP, Taylor GW, Maltby NH, Siegers D, Fuller RW, Dollery CT, Williams R.

J Hepatol. 1990 Sep;11(2):263-71.

PMID:
2174935
40.

Urinary N tau-methylimidazole acetic acid excretion in respiratory disease.

Taylor IK, O'Malley G, Murray S, Turner N, Taylor GW, Fuller RW, Pride N, Dollery CT.

J Appl Physiol (1985). 1990 Aug;69(2):591-6.

PMID:
2228870
41.

Cerebral mass lesions in patients with AIDS.

Montgomery H, Adam A, Dollery CT, Weber J, Volberding P, Griffin B, Scaravilli F.

BMJ. 1990 Jul 28;301(6745):226-8. No abstract available.

42.

Autoradiographic localization of atrial natriuretic peptide receptor subtypes in rat kidney.

Brown J, Salas SP, Singleton A, Polak JM, Dollery CT.

Am J Physiol. 1990 Jul;259(1 Pt 2):F26-39.

PMID:
2165358
43.

Life threatening thrombocytopenia in sarcoidosis.

Larner AJ, Dollery CT, Cox TM, Bloom SR, Scadding JG, Rees AJ.

BMJ. 1990 Feb 3;300(6720):317-9. No abstract available.

44.

Leukotriene C4 elimination and metabolism in man.

Maltby NH, Taylor GW, Ritter JM, Moore K, Fuller RW, Dollery CT.

J Allergy Clin Immunol. 1990 Jan;85(1 Pt 1):3-9.

PMID:
2299103
45.

Central bronchogenic cyst: treatment by extrapleural percutaneous aspiration.

Whyte MK, Dollery CT, Adam A, Ind PW.

BMJ. 1989 Dec 9;299(6713):1457-8. No abstract available.

46.

Campylobacter pylori, duodenal ulcer disease, and gastrin.

Levi S, Dollery CT, Bloom SR, Calam J, Cox TM, Hodgson HJ, Losowsky MS, Pepys MB, Wright NA, Wrong OM.

BMJ. 1989 Oct 28;299(6707):1093-4. No abstract available.

47.

Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine.

Barrow SE, Ward PS, Sleightholm MA, Ritter JM, Dollery CT.

Biochim Biophys Acta. 1989 Oct 13;993(1):121-7.

PMID:
2679889
48.
49.

Formation of endothelin by cultured airway epithelial cells.

Black PN, Ghatei MA, Takahashi K, Bretherton-Watt D, Krausz T, Dollery CT, Bloom SR.

FEBS Lett. 1989 Sep 11;255(1):129-32.

50.

Systemic candidiasis: an unusual complication of eating mutton.

Bates J, Dollery CT, Cohen J, Schulenburg E, Calam J.

BMJ. 1989 Aug 26;299(6698):557-8. No abstract available.

Supplemental Content

Loading ...
Support Center